Changchun hi tech fell more than 8% in intraday diving

Big Pharma CCHT’s Domination Unlikely to Fade Soon Despite Official Bulk Buying

The producer of long-acting growth hormone acupunctures, vaccines and other drugs, looks set to offset the effects of so-called “centralized procurement” on its product prices with more aggressive expansion into private hospitals. So far, its monopoly appears unshakable, but with more competitors upping the stakes, how long will it last?

Unpacking China | Key Chinese Firms to Watch This Week （26/07/2026-01/08/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Zhongji InnoLight Prices Hong Kong Listing at HK$980, Raising HK$53.41 Billion

Zhongji InnoLight Co., Ltd.（中际旭创股份有限公司）, a leading Chinese supplier of optical transceivers used in cloud and artificial-intelligence infrastructure, has priced its Hong Kong H-share offering at HK$980 per share, giving the base deal gross proceeds of HK$53.41 billion (US$6.81 billion).

Unpacking China | Key Chinese Firms to Watch This Week （19/07/2026-25/07/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.

Unpacking China | Key Chinese Firms to Watch This Week （05/07/2026-11/07/2026）

Amid fast-paced changes that fill the business community with excitement, angst and trepidation, EqualOcean will publish a series of roundup articles to document the major events related to Chinese companies going global every week.